Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 26 for “"M2e"”.
-
Evaluation of Sindbis-M2e Virus Vector as a Universal Influenza A Vaccine
… vector expressing the PR8 influenza strain's M2e peptide was developed as a potential universal DIVA vaccine. M2e is a conserved peptide amongst influenza A viruses; M2e-specific antibodies induce antibody-dependent cytotoxicity or phagocytosis of infected cells, reducing production and …
-
TARGETING THE 'UNIVERSAL' INFLUENZA A VACCINE CANDIDATE M2E TO CLEC9A - EXPRESSING DENDRITIC CELLS
… 24-amino acid ectodomain of M2 protein (M2e), but its poor immunogenicity has been a major roadblock in its clinical development. Here, we report a targeting strategy that shuttles M2e to a specific sub-population of dendritic cells (cDC1) by engineering a chimeric anti-Clec9A monoclonal …
-
Development of universal influenza A vaccine based on conserved viral protein M2e and its nanocarriers
… extracellular region of the matrix 2 protein (M2e) present on influenza A virus is a remarkably conserved but poorly immunogenic if administered alone. In this dissertation, we established a universal influenza vaccine based on conjugating M2e protein to gold nanoparticles (AuNPs) to create …
-
Avian Influenza virus M2e protein: Epitope mapping, competitive ELISA and phage displayed scFv for DIVA in H5N1 serosurveillance
… on the AIV matrix 2 extracellular domain (M2e) protein has propelled its exploration as the target for AIV serosurveillance diagnostic tool development. It has been demonstrated to be highly sensitive and specific in detection for AIV infection in an indirect enzyme-linked immunosorbent …
-
The Formation of Novel Peptide Nanoclusters via Di-tyrosine Bond Formation for use as a Universal Influenza Vaccination Platform
… bonding within a conserved influenza antigen, M2e. Nanoclusters of pure M2e antigen are fabricated using a tyrosine-tyrosine cross-linking reaction and then used to elicit an immune response against M2e within BALB/c mice. Two methods of cluster formation are described and analyzed for the …
-
Modulation de l'auto-assemblage de peptides en nanostructures protéiques à des fins vaccinales
… de l’ectodomaine de la protéine de matrice M2 (M2e) du VI. L’antigène M2e a été ciblé pour le développement d’un vaccin universel contre la grippe. Une augmentation significative des anticorps sériques dirigés contre l’épitope M2e a été observée chez des souris immunisées avec des assemblages …
-
Development and characterization of a novel DC-targeting universal influenza vaccine
… conserved antigens like influenza HA stalk and M2e hold promise for a universal influenza vaccine but suffer from low immunogenicity, necessitating enhancement. To improve the immunogenicity of the influenza HA stalk and M2e, the DC-targeting domain of EboGP (EΔM) was fused with the influenza …
-
Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization
… influenza A virus, the M2 extracellular domain (M2e), in the viral life cycle; this region has become a major molecular target for universal IAV vaccines. Using in vitro transcomplementation assays with cell lines stably expressing M2e mutants, we determined that this region of the M2 protein is …
-
Swine Influenza Virus : Innate Immune Responses and Vaccine Development
… extracellular domain of Matrix protein 2 (M2e) of influenza virus as candidate. Four repeats of M2e gene were inserted into recombinant adenovector (Adeno-M2e) that could transiently express the protein. Twenty-five gnotobiotic pigs were divided in to 5 groups: 1) Mock-vaccination group …
-
Development of Bordetella pertussis as a live vehicles for heterologous antigens delivery, and its application as a universal influenza A vaccine
… A viruses, namely the ectodomain of M2 protein (M2e), 3 conserved neutralizing epitopes in H5 and the nucleocapsid protein (NP) were selected and expressed in attenuated B. pertussis BPZE1. These antigens were either expressed in the cytoplasm of B. pertussis or secreted into the external milieu …
-
Implementing new nutrition care practices in healthcare: learning from the experience of health professionals in hospitals and Family Health Teams.
… dissertation are components of the More-2-Eat (M2E) study, which aimed to improve nutrition care by implementing the Integrated Nutrition Pathway for Acute Care (INPAC) in five hospital units across Canada. In Part 1, a knowledge, attitudes and practices (KAP) questionnaire was developed and …
-
Tailored influenza virus vaccines for both the young and old: Vaccine Efficacy of Whole Inactivated Vaccines bearing Immunomodulatory Adjuvants or Multimeric peptides
… In addition, we tested whether a multimeric M2e peptide presented on WIV can serve to enhance immunogenicity and augment protective efficacy of whole virus vaccines. Our panel of cytokines includes IL-2, IL-4, IL-12, IL-23, and Flt3L as well as the multimeric M2e peptide, all fused to the …
-
Preparation and Evaluation of Single-Stranded DNA Aptamer-Based Immunological Adjuvant in Broiler Chickens
… of the highly conserved type-A influenza peptide M2e. This conjugate was administered subcutaneously at either (25μg/bird) or (50μg/bird) at age 7 and 21 days. Anti-M2e IgG responses were determined at 14, 21, 28 and 35 days of age by ELISA. The RCA-p-M2e complex, at 50μg/bird, was able to induce …
-
Exploring the Immunostimulatory Properties of GAS Pili
… to the low immunogenicity influenza antigen M2e resulted in enhanced M2e specific antibody production. These results uncovered the previously undiscovered characteristics of GAS pilus proteins being TLR2 agonists with the ability to prime innate immune cells to enhance adaptive immune …
-
Protein nanoparticle vaccines
… made from conserved influenza matrix protein 2 (M2e) trigger specific, adaptive immune responses that soluble protein cannot. Without excipients or adjuvants, protein nanoparticles eliminate the possibility of off-target immune responses, and their abiotic nature makes them amenable to cold …
-
Development of a Novel Nanotechnology-Based Vaccine Adjuvant and Delivery System for Systemic and Mucosal Immunity
… InAc-NPs carrying the influenza peptide (M2e) produced higher mucosal and systemic antibodies compared to unadjuvanted antigen in pigs. The study, for the first time, showed InAc as a vaccine adjuvant in pigs that will have significant implications in swine industry and human health. In …
-
ENGINEERING ESCHERICHIA COLI OUTER MEMBRANE VESICLES AND OUTER MEMBRANE PROTEINS FOR SUBUNIT ANTIGEN DELIVERY AND VACCINE DESIGN
… construct of influenza A matrix protein 2 (M2e4xHet) as the model antigen. The immunizations did not protect the mice, but ClyA-M2e4xHet protein induced comparable anti-M2e IgG titers comparable to those induced by ClyA-M2e4xHet OMVs. This research expands the capabilities of OMV vaccines, …
-
Development of an Antibiotic Resistance Free Bivalent Vaccine Against Swine Brucellosis and Swine Influenza
… HA, NP and ectodomain of matrix protein M2e, were not found to be expressing even after optimizing their codon usage to suit Brucella tRNA preference. However, RT-PCR showed that the influenza genes mRNA were produced. In conclusion, this dissertation describes the construction of an …
-
Influenza vaccines and antivirals that target the conserved hemagglutinin stem
… (NP), and the ectodomain of the matrix protein (M2e) in nonhuman primates. Though the LT-MA DNA vaccine induced robust serum and mucosal antibody responses, it failed to induce broadly neutralizing antibodies. These results demonstrate that vaccination with full-length HA immunogen does not …
Page 1 of 2